Company: Pfizer Rare Disease
Job title: Director, Patient Advocacy, Global Product Development
Dr Nicolas Garnier is the Director of Patient Advocacy for RD-GPD.
Nicolas is a scientist by training and published author. He completed his Master’s degree in Genetics at Denis Diderot University (Paris, France), before completing his PhD degree in Experimental Medicine at McGill University (Montreal, Canada) in 2013. He also studied the functional genomics of pediatric leukemia at Sainte-Justine Hospital (Montreal, Canada) as a Postdoctoral Fellow before joining Pfizer Canada Medical Affairs in 2015.
Before his current role, Nicolas was the Senior Manager Access for Pfizer Canada Rare Disease, where he was responsible for Market Access, HEOR, as well as Policy, since early 2018.
Patient advocacy and disease awareness is a life-long passion for Nicolas.
He has built strong relationships with Patient Groups in the Rare Disease and the Oncology space.
In his role as Director of Patient Advocacy, Nicolas helps the Pfizer Rare Disease clinical teams design and execute development programs that positively impact the lives of patients and the Rare Disease community.
Running Patient-Centric Gene Therapy Programs to Optimize Success 1:15 pm
Utilizing patient advocacy connections to gain full understanding into patient needs Informing drug development decisions through insights into clinical unmet need Incorporating patient engagement initiatives in internal development strategies for truly valuable pipeline developmentRead more
day: Day Two